Radiotherapy and time to initial treatment following a cancer diagnosis among First Nations Australians: results from a population-based analysis
- PMID: 40481575
- PMCID: PMC12142829
- DOI: 10.1186/s13690-025-01638-9
Radiotherapy and time to initial treatment following a cancer diagnosis among First Nations Australians: results from a population-based analysis
Abstract
Background: First Nations Australians experience poorer cancer outcomes than other Australians. This is attributable to multidimensional factors, including disparities in access to cancer services and treatments. Radiotherapy (RT) is an important component of cancer treatment yet evidence of its utilisation among First Nations Australians is limited. We aimed to examine RT utilisation, time to the treatment, and associated factors in First Nations Peoples diagnosed with cancer in Queensland, Australia.
Methods: First Nations Queenslanders (N = 1884) and other Queenslanders (N = 104,204) diagnosed with any cancer between 1st July 2011 and 30th June 2015 and their RT details between 1st July 2011 and 30th June 2018 were identified using the Cancer CostMod dataset, comprising Queensland Cancer Registry data linked with Queensland Hospital Admitted Patient Data Collection (QHAPDC) and Medicare Benefits Schedule (MBS). Analysis was limited to those with non-missing Indigenous status who linked to MBS and/or QHAPDC records (N = 105, 983). Differences in RT utilisation and waiting times by First Nations status were tested using logistic regressions, non-parametric tests, and quantile regression.
Results: Among 105, 983 people with a cancer diagnosis in Queensland, 28.6% had RT, with external Beam RT(EBRT) as the predominant type (n = 29,387, 96.9%). One-third (33.5%) of First Nations cancer patients received RT at least once, compared to 28.5% of other Queensland cancer patients (P < 0.001). After adjustment for covariates, First Nations cancer patients had a greater likelihood of RT utilisation than other Queenslanders (adjusted odds ratio(aOR): 1.15; 95% (confidence-interval (CI): 1.04-1.27) and more pronounced within the first year after diagnosis (aOR: 1.23: 95% CI:1.11-1.37). Among those receiving any RT, the median time from cancer diagnosis to first RT was 118 days (Interquartile-range (IQR): 55-232) for First Nations and 132 days (IQR: 59-258) for other Queenslanders (P = 0.034).
Conclusions: A higher proportion of First Nations cancer patients received RT than other Queensland cancer patients, particularly in the first year following diagnosis. However, RT utilisation for all cancer patients was notably lower (28.6%) than the national optimal RT(EBRT) rate of 48%. This finding highlights the need for RT to align with optimal care standards, which is crucial for improving cancer outcomes.
Keywords: Cancer; Indigenous; Queensland; Radiotherapy; Time to initial treatment; Utilisation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Approval was obtained from the following Human Research Ethics Committees (HRECs): Townsville Hospital and Health Service (HREC/16/QTHS/110); Australian Institute of Health and Welfare (EO2017/1/343); James Cook University (H6678); and The University of Queensland (2022/HE002538: 23/01/2023). Queensland Health waived the requirement for individual consent under the Public Health Act 2005. No identifiable information was disclosed to the study team. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
Quantifying the Diagnosis and Survival of Early Onset Bowel Cancer Among First Nations Peoples in Queensland, Australia.Cancer Med. 2025 Mar;14(6):e70821. doi: 10.1002/cam4.70821. Cancer Med. 2025. PMID: 40116434 Free PMC article.
-
Health care service use by people diagnosed with invasive melanoma in Queensland: a benefit incidence analysis.Med J Aust. 2023 Nov 6;219(9):417-422. doi: 10.5694/mja2.52122. Epub 2023 Oct 9. Med J Aust. 2023. PMID: 37807891
-
Cancer survival differentials for Aboriginal and Torres Strait Islander peoples in Queensland: the impact of remoteness.Cancer Causes Control. 2023 Jan;34(1):13-22. doi: 10.1007/s10552-022-01643-1. Epub 2022 Oct 20. Cancer Causes Control. 2023. PMID: 36266522 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Utilisation of endocrine therapy for cancer in Indigenous peoples: a systematic review and meta-analysis.BMC Cancer. 2024 Jul 22;24(1):882. doi: 10.1186/s12885-024-12627-6. BMC Cancer. 2024. PMID: 39039483 Free PMC article.
References
-
- Australian Institute of Health and Welfare. Cancer data in Australia. Canberra: Australian Institute of Health and Welfare, 2023 [cited 2024 Apr. 20]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia.
-
- Australian Institute of Health and Welfare. Cancer in aboriginal & Torres strait islander people of Australia. (2018). Canberra: AIHW. [Available from: https://www.aihw.gov.au/reports/cancer/cancer-in-indigenous-australians/...]
-
- Australian Institute of Health and Welfare. Cancer in Australia 2021. Canberra: AIHW. 2021. [Available from: 10.25816/ye05-nm50]
-
- Queensland Health. 2024, Achieving health equity in cancer care with Aboriginal and Torres Strait Islander Queenslanders.
Grants and funding
- 1153027/National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians
- 1153027/National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians
- 1153027/National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians
- 1153027/National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians
- 1153027/National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians
LinkOut - more resources
Full Text Sources